The first [18F]THK-5105 (Figure 3b) PET study showed differentiation of AD patients from HCs, and mismatch with the binding pattern of [11C]PiB (Figure 1f) [63], despite fairly high nonspecific binding of the tau tracer in white matter, brainstem, and thalamus [111]. Here, MAPT is linked to Alzheimer disease.